FIMM HiLIFE Unit logo black
The Ripatti group studies genetics of common complex diseases from discovery to translation to health care. We utilize Finnish research cohorts and a global network of biobank data with longitudinal health event histories to identify genetic associations and potential causal variants modifying the risks of diseases. We also develop and test risk models to stratify individuals based on their risks for preventive actions or stratified treatment. With health care partners, we develop approaches to apply these models in routine health care.
Institute for Molecular Medicine Finland FIMM

Follow us on Twitter

@CoECDG

Laaja #FinnGen-aineistoon perustuva HY:n ja HUSin yhteistyönä toteutettu tutkimus on tunnistanut viisi uniapnealle… twitter.com/i/web/status/1…

Our GWAS (led by Satu Strautz) on sleep apnea risk in FinnGen is now out. Highlights: five risk loci, causal link w… twitter.com/i/web/status/1…

We are excited to announce our COVID-19 Host Genetics @DNAday Tweet-a-thon next Friday, April 23. Follow along to m… twitter.com/i/web/status/1…

Diabetestutkimus esillä tämän päivän Helsingin Sanomissa: ”Tyypin 2 diabetes eli niin sanottu aikuistyypin diabetes… twitter.com/i/web/status/1…